SGRY icon

Surgery Partners

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 66.7%
Negative

Neutral
GlobeNewsWire
5 days ago
Surgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2025 results after market close on Monday, March 2, 2026, to be followed by a conference call on Tuesday, March 3, 2026 at 8:30 a.m. (Eastern Time).
Surgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call Details
Negative
The Motley Fool
6 days ago
Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million
Irenic Capital sold 1,047,583 shares of Surgery Partners in the fourth quarter; the estimated transaction value was $19.25 million based on average fourth-quarter pricing. The quarter-end position value decreased by $23.19 million, reflecting both share sales and price changes.
Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million
Positive
Zacks Investment Research
17 days ago
Surgery Partners (SGRY) Moves 7.7% Higher: Will This Strength Last?
Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Surgery Partners (SGRY) Moves 7.7% Higher: Will This Strength Last?
Neutral
GlobeNewsWire
2 months ago
Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering
BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), priced $425.0 million aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the “Notes”) in a previously announced private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The offering is expected to close on December 16, 2025, subject to certain customary closing conditions. The Notes will be guaranteed (the “Guarantees”) on a senior unsecured basis by each domestic wholly-owned subsidiary of the Issuer that guarantees the Issuer's obligations under its senior secured credit facilities. The notes will be issued as part of the same series as the $800.0 million of 7.250% senior notes due 2032 originally issued in April 2024.
Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering
Neutral
PRNewsWire
2 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY
NEW YORK , Dec. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Surgery Partners, Inc. ("Surgery Partners" or the "Company") (NASDAQ: SGRY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY
Neutral
GlobeNewsWire
2 months ago
Surgery Partners, Inc. Announces Add-On Senior Notes Offering
BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company (the “Issuer”), intends to offer, subject to market and other considerations, an additional $425.0 million aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the “Notes”). The Notes will be guaranteed (the “Guarantees”) on a senior unsecured basis by each domestic wholly-owned subsidiary of the Issuer that guarantees its obligations under its senior secured credit facilities. The notes will be issued as part of the same series as the Issuer's 7.250% senior notes due 2032 originally issued in April 2024.
Surgery Partners, Inc. Announces Add-On Senior Notes Offering
Neutral
PRNewsWire
3 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY
NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Surgery Partners, Inc. ("Surgery Partners" or the "Company") (NASDAQ: SGRY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY
Negative
The Motley Fool
3 months ago
Why Surgery Partners Stock Plummeted on Monday
It missed on the top line and whiffed significantly on analyst estimates in its third quarter. The company did manage to grow its revenue by almost 7% year over year.
Why Surgery Partners Stock Plummeted on Monday
Neutral
Seeking Alpha
3 months ago
Surgery Partners, Inc. (SGRY) Q3 2025 Earnings Call Transcript
Surgery Partners, Inc. ( SGRY ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants David Doherty - Executive VP & CFO J. Evans - CEO & Director Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Andrew Mok - Barclays Bank PLC, Research Division Sarah James - Cantor Fitzgerald & Co., Research Division Benjamin Mayo - Leerink Partners LLC, Research Division William Sutherland - The Benchmark Company, LLC, Research Division Ryan Langston - TD Cowen, Research Division Presentation Operator Greetings, and welcome to the Surgery Partners' Third Quarter 2025 Earnings Call.
Surgery Partners, Inc. (SGRY) Q3 2025 Earnings Call Transcript
Negative
Zacks Investment Research
3 months ago
Surgery Partners (SGRY) Q3 Earnings and Revenues Lag Estimates
Surgery Partners (SGRY) came out with quarterly earnings of $0.13 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.19 per share a year ago.
Surgery Partners (SGRY) Q3 Earnings and Revenues Lag Estimates